Case Study: Global Healthcare Fortune 500 Drug Manufacturing Company secures better vaccine market intelligence and saves $250K with AgileOne

Rigorous supplier vetting leads to cost savings for new product launch

Global Healthcare Fortune 500 Drug Manufacturing Company, a global U.S.-based research-driven pharmaceutical company, needed market intelligence for a new vaccine launch within a tight timeframe. Its long-standing preferred provider lacked direct experience in vaccine market research, so the company turned to AgileOne for services procurement support.

AgileOne developed a formal RFP, invited four suppliers to compete, and used an objective evaluation matrix to score commercial and technical criteria with client stakeholders. This fair, quantitative process selected a supplier with more relevant experience and lower cost, with the winning proposal coming in approximately $250,000 below the other bidders.